Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD

Clinical trial NCT05507242 · RECRUITING

Trial details

NCT number: NCT05507242
Sponsor: Asger Sverrild
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

COPD COPD Exacerbation COPD Bronchitis Airway Disease Immune System Disorder

Start date: 2022-10-25
Primary completion: 2025-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.